Anticipate generic drug launch
Find generic entry opportunities
Proactively manage your pharmacy inventory
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
|Title:||Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension|
|Abstract:||Disclosed is the use of cloprostenol and fluprostenol analogues for the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic compositions comprising said compounds.|
|Inventor(s):||Klimko; Peter G. (Fort Worth, TX), Bishop; John E. (Groton, MA), Sallee; Verney L. (Burleson, TX), Zinke; Paul W. (Fort Worth, TX)|
|Assignee:||Alcon Laboraties, Inc. (Fort Worth, TX)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Compound;|
Field: Not categorized
Back Citations: 25th percentile
Forward Citations: 1st percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.